The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
Abstract
The risk of breast and ovarian cancer among women with mutations such as BRCA1 and BRCA2 mutations can be mitigated by operations to remove the organs at greatest risk. Data are presented to assist in deciding what operation should be performed and when it should occur.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Very high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,445
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,423
Self-citationA breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn442 · Cited by 939
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Self-citationGene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
Edwards, B. K., Howe, H. L., Ries, L. A. G., Thun, M. J., Rosenberg, H. M., Yancik, R., Wingo, P. A., Jemal, A., & Feigal, E. G. (2002) · Cancer · doi:10.1002/cncr.10593 · Cited by 880
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
Self-citationMeindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., Freund, M., Lichtner, P., Hartmann, L., Schaal, H., et al. (2010) · Nature Genetics · doi:10.1038/ng.569 · Cited by 743
Self-citationBreast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 672
Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., Ramus, S. J., Spurdle, A., Robson, M., Sherman, M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0775 · Cited by 669
Self-citationImpact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Finch, A. P. M., Lubinski, J., Møller, P., Singer, C. F., Karlan, B., Senter, L., Rosen, B., Maehle, L., Ghadirian, P., Cybulski, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.2820 · Cited by 664
BOCS, Michailidou, K., kConFab Investigators, AOCS Group, NBCS, GENICA Network, Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3242 · Cited by 598
Kauff, N. D., Domchek, S. M., Friebel, T. M., Robson, M. E., Lee, J., Garber, J. E., Isaacs, C., Evans, D. G., Lynch, H., Eeles, R. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9626 · Cited by 589
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study
Rocca, W. A., Grossardt, B. R., de Andrade, M., Malkasian, G. D., & Melton, L. J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70869-5 · Cited by 547
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Rebbeck, T. R., Mitra, N., Wan, F., Sinilnikova, O. M., Healey, S., McGuffog, L., Mazoyer, S., Chenevix-Trench, G., Easton, D. F., Antoniou, A. C., et al. (2015) · JAMA · doi:10.1001/jama.2014.5985 · Cited by 521
Self-citationGermline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Ramus, S. J., Song, H., Dicks, E., Tyrer, J. P., Rosenthal, A. N., Intermaggio, M. P., Fraser, L., Gentry-Maharaj, A., Hayward, J., Philpott, S., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv214 · Cited by 437
Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers
Tai, Y. C., Domchek, S., Parmigiani, G., & Chen, S. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm203 · Cited by 430
Rebbeck, T. R., Friebel, T., Wagner, T., Lynch, H. T., Garber, J. E., Daly, M. B., Isaacs, C., Olopade, O. I., Neuhausen, S. L., van ′t Veer, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.8151 · Cited by 411
Vasen, H. F. A., Stormorken, A., Menko, F. H., Nagengast, F. M., Kleibeuker, J. H., Griffioen, G., Taal, B. G., Moller, P., & Wijnen, J. T. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4074 · Cited by 406
BRCA2 germline mutations in male breast cancer cases and breast cancer families
Couch, F. J., Farid, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-123 · Cited by 363
INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES
Tobacman, J., Tucker, M., Kase, R., Greene, M., Costa, J., & Fraumeni, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92681-2 · Cited by 351
Song, H., Dicks, E., Ramus, S. J., Tyrer, J. P., Intermaggio, M. P., Hayward, J., Edlund, C. K., Conti, D., Harrington, P., Fraser, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2408 · Cited by 328
Domchek, S. M., Friebel, T. M., Neuhausen, S. L., Wagner, T., Evans, G., Isaacs, C., Garber, J. E., Daly, M. B., Eeles, R., Matloff, E., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70585-x · Cited by 327
Frost, M. H. (2000) · JAMA · doi:10.1001/jama.284.3.319 · Cited by 325
Nelson, H. D., Pappas, M., Zakher, B., Mitchell, J. P., Okinaka-Hu, L., & Fu, R. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1684 · Cited by 319
Barrow, E., Robinson, L., Alduaij, W., Shenton, A., Clancy, T., Lalloo, F., Hill, J., & Evans, D. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01125.x · Cited by 318
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Graeser, M. K., Engel, C., Rhiem, K., Gadzicki, D., Bick, U., Kast, K., Froster, U. G., Schlehe, B., Bechtold, A., Arnold, N., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9430 · Cited by 314
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
Meijers-Heijboer, E., Verhoog, L., Brekelmans, C., Seynaeve, C., Tilanus-Linthorst, M., Wagner, A., Dukel, L., Devilee, P., van den Ouweland, A., van Geel, A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02347-3 · Cited by 307
Metcalfe, K., Gershman, S., Ghadirian, P., Lynch, H. T., Snyder, C., Tung, N., Kim-Sing, C., Eisen, A., Foulkes, W. D., Rosen, B., et al. (2014) · BMJ · doi:10.1136/bmj.g226 · Cited by 305
Moorman, P. G., Havrilesky, L. J., Gierisch, J. M., Coeytaux, R. R., Lowery, W. J., Peragallo Urrutia, R., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9021 · Cited by 303
Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis
Iodice, S., Barile, M., Rotmensz, N., Feroce, I., Bonanni, B., Radice, P., Bernard, L., Maisonneuve, P., & Gandini, S. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.018 · Cited by 281
Warner, E., Hill, K., Causer, P., Plewes, D., Jong, R., Yaffe, M., Foulkes, W. D., Ghadirian, P., Lynch, H., Couch, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0835 · Cited by 280
Brandberg, Y., Sandelin, K., Erikson, S., Jurell, G., Liljegren, A., Lindblom, A., Lindén, A., von Wachenfeldt, A., Wickman, M., & Arver, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9568 · Cited by 265
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
Walker, J. L., Powell, C. B., Chen, L., Carter, J., Bae Jump, V. L., Parker, L. P., Borowsky, M. E., & Gibb, R. K. (2015) · Cancer · doi:10.1002/cncr.29321 · Cited by 241
Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk
Hwang, S.-J., Lozano, G., Amos, C. I., & Strong, L. C. (2003) · The American Journal of Human Genetics · doi:10.1086/374567 · Cited by 229
The Consortium of Investigators of Modifiers of BRCA1/2, Lee, A. J., The Breast Cancer Association Consortium, Cunningham, A. P., Kuchenbaecker, K. B., Mavaddat, N., Easton, D. F., & Antoniou, A. C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.730 · Cited by 214
Heemskerk-Gerritsen, B. A. M., Seynaeve, C., van Asperen, C. J., Ausems, M. G. E. M., Collée, J. M., van Doorn, H. C., Gomez Garcia, E. B., Kets, C. M., van Leeuwen, F. E., Meijers-Heijboer, H. E. J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv033 · Cited by 206
Menon, U., Ryan, A., Kalsi, J., Gentry-Maharaj, A., Dawnay, A., Habib, M., Apostolidou, S., Singh, N., Benjamin, E., Burnell, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4945 · Cited by 196
Malone, K. E., Begg, C. B., Haile, R. W., Borg, A., Concannon, P., Tellhed, L., Xue, S., Teraoka, S., Bernstein, L., Capanu, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2495 · Cited by 191
Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected
Sung, H., Rosenberg, P. S., Chen, W.-Q., Hartman, M., Lim, W.-Y., Chia, K. S., Wai-Kong Mang, O., Chiang, C.-J., Kang, D., Ngan, R. K.-C., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv107 · Cited by 175
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Phillips, K.-A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C., Peock, S., Frost, D., Easton, D. F., Ellis, S., Friedlander, M. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.8313 · Cited by 171
Incidence of Metachronous Testicular Cancer in Patients With Extragonadal Germ Cell Tumors
Hartmann, J. T., Fossa, S. D., Nichols, C. R., Droz, J.-P., Horwich, A., Gerl, A., Beyer, J., Pont, J., Fizazi, K., Hecker, H., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1733 · Cited by 162
Hatcher, M. B. (2001) · BMJ · doi:10.1136/bmj.322.7278.76 · Cited by 160
Heemskerk-Gerritsen, B. A. M., Brekelmans, C. T. M., Menke-Pluymers, M. B. E., van Geel, A. N., Tilanus-Linthorst, M. M. A., Bartels, C. C. M., Tan, M., Meijers-Heijboer, H. E. J., Klijn, J. G. M., & Seynaeve, C. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9449-x · Cited by 153
Inherited predisposition to breast cancer among African American women
Churpek, J. E., Walsh, T., Zheng, Y., Moton, Z., Thornton, A., Lee, M. K., Casadei, S., Watts, A. C., Neistadt, B., Churpek, M. M., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3195-0 · Cited by 144
Kramer, J. L., Velazquez, I. A., Chen, B. E., Rosenberg, P. S., Struewing, J. P., & Greene, M. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9199 · Cited by 135
Ovarian Cancer is an Imported Disease: Fact or Fiction?
Kuhn, E., Kurman, R. J., & Shih, I. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-011-0004-1 · Cited by 127
Pilarski, R., Cebulla, C. M., Massengill, J. B., Rai, K., Rich, T. A., Strong, L. C., McGillivray, B., Asrat, M., Davidorf, F. H., & Abdel‐Rahman, M. H. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22129 · Cited by 122
Skytte, A., Gerdes, A., Andersen, M., Sunde, L., Brøndum‐Nielsen, K., Waldstrøm, M., Kølvraa, S., & Crüger, D. G. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01329.x · Cited by 122
Giuliano, A. E., Boolbol, S. K., Degnim, A. C., Kuerer, H. M., Leitch, A. M., & Morrow, M. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9447-z · Cited by 116
Finch, A., Metcalfe, K. A., Chiang, J., Elit, L., McLaughlin, J. R., Springate, C., Esplen, M. J., Demsky, R., Murphy, J., Rosen, B. P., et al. (2011) · Psycho-Oncology · doi:10.1002/pon.2041 · Cited by 104
Primary Breast Cancer After Prophylactic Mastectomy
Ziegler, L. D., & Kroll, S. S. (1991) · American Journal of Clinical Oncology · doi:10.1097/00000421-199110000-00018 · Cited by 103
Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers
Beattie, M. S., Crawford, B., Lin, F., Vittinghoff, E., & Ziegler, J. L. (2009) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2008.0067 · Cited by 99
Karppinen, S., Heikkinen, K., Rapakko, K., & Winqvist, R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020669 · Cited by 98
Friebel, T. M., Domchek, S. M., Neuhausen, S. L., Wagner, T. M., Evans, D. G., Isaacs, C. J., Garber, J. E., Daly, M. B., Eeles, R. A., Matloff, E. T., et al. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.n.053 · Cited by 93
Brohet, R. M., Velthuizen, M. E., Hogervorst, F. B. L., Meijers-Heijboer, H. E. J., Seynaeve, C., Collee, M. J., Verhoef, S., Ausems, M. G. E. M., Hoogerbrugge, N., van Asperen, C. J., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101974 · Cited by 90
Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers
Singh, K., Lester, J., Karlan, B. Y., Bresee, C. J., Geva, T., & Gordon, O. K. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.026 · Cited by 89
Risk reducing mastectomy: outcomes in 10 European centres
Evans, D. G., Baildam, A. D., Anderson, E. D. C., Brain, A., Shenton, A., Vasen, H. F. A., Eccles, D., Lucassen, A., Pichert, G., Hamed, H., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062232 · Cited by 87
Byrnes, G. B., Southey, M. C., & Hopper, J. L. (2008) · Breast Cancer Research · doi:10.1186/bcr2099 · Cited by 83
Contant, C., Menke-Pluijmers, M., Seynaeve, C., Meijers-Heijboer, E. J., Klijn, J. G., Verhoog, L., Wai, R. T. J., Eggermont, A., & van Geel, A. V. (2002) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1279 · Cited by 78
Potential for Bias in Studies on Efficacy of Prophylactic Surgery for BRCA1 and BRCA2 Mutation
Klaren, H. M., Veer, L. J. V., van Leeuwen, F. E., & Rookus, M. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.941 · Cited by 78
Breast cancer after bilateral risk-reducing mastectomy
Skytte, A., Crüger, D. G., Gerster, M., Lænkholm, A., Lang, C., Brøndum‐Nielsen, K., Andersen, M., Sunde, L., Kølvraa, S., & Gerdes, A. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01604.x · Cited by 76
Salpingectomy as a Means to Reduce Ovarian Cancer Risk
Daly, M. B., Drescher, C. W., Yates, M. S., Jeter, J., Karlan, B. Y., Alberts, D. S., & Lu, K. H. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0293 · Cited by 75
The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland
Stacey, S., Sulem, P., Johannsson, O. T., Helgason, A., Guðmundsson, J., Kostic, J. P., Kristjánsson, K., Jonsdottir, T. E., Sigurdsson, H., Hrafnkelsson, J., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030217 · Cited by 75
Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey
Arver, B. W., Isaksson, K., Atterhem, H., Baan, A., Bergkvist, L., Brandberg, Y., Ehrencrona, H., Emanuelsson, M., Hellborg, H., Henriksson, K. M., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e318214b55a · Cited by 72
van Dijk, S., van Roosmalen, M. S., Otten, W., & Stalmeier, P. F. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5494 · Cited by 70
Challenging and Complex Decisions in the Management of the BRCA Mutation Carrier
Stan, D. L., Shuster, L. T., Wick, M. J., Swanson, C. L., Pruthi, S., & Bakkum-Gamez, J. N. (2013) · Journal of Women s Health · doi:10.1089/jwh.2013.4407 · Cited by 66
Prokofyeva, D. S., Bogdanova, N. V., Dubrowinskaja, N., Bermisheva, M., Takhirova, Z., Antonenkova, N., Turmanov, N., Datsyuk, I., Gantsev, S. K., Christiansen, H., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2357-1 · Cited by 64
Total Skin-Sparing Mastectomy in BRCA Mutation Carriers
Peled, A. W., Irwin, C. S., Hwang, E. S., Ewing, C. A., Alvarado, M. D., & Esserman, L. J. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3230-0 · Cited by 62
Møller, P., Stormorken, A. T., Jonsrud, C., Holmen, M. M., Hagen, A. I., Clark, N., Vabø, A., Sun, P., Narod, S. A., & Mæhle, L. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2540-z · Cited by 59
Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriers
Collins, I. M., Milne, R. L., Weideman, P. C., McLachlan, S., Friedlander, M. L., Hopper, J. L., & Phillips, K. (2013) · The Medical Journal of Australia · doi:10.5694/mja13.10848 · Cited by 58
Heiniger, L. E., Butow, P. N., Coll, J. R., Bullen, T., Wilson, J., Baylock, B., Meiser, B., & Price, M. A. (2014) · Familial Cancer · doi:10.1007/s10689-014-9759-7 · Cited by 50
Klitzman, R., & Chung, W. K. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33068 · Cited by 50
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer
Antill, Y. C., Reynolds, J., Young, M., Kirk, J., Tucker, K., Bogtstra, T. L., Wong, S., Dudding, T. E., Iulio, J. D., & Phillips, K. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.020 · Cited by 42
Vos, J. R., Hsu, L.-I., Brohet, R. M., Mourits, M. J. E., de Vries, J., Malone, K. E., Oosterwijk, J. C., & de Bock, G. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.0463 · Cited by 34
How Well Does Supplemental Screening Magnetic Resonance Imaging Work in High-Risk Women?
Berg, W. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2975 · Cited by 16
Vaginal progesterone or cerclage to prevent recurrent preterm birth?
Combs, C. A. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.031 · Cited by 16
A survey of preventive measures among BRCA1 mutation carriers from Poland
Gronwald, J., Byrski, T., Huzarski, T., Cybulski, C., Stawicka, M., Szwiec, M., Dębniak, T., Tulman, A., Sun, P., Oszurek, O., et al. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00742.x · Cited by 15
Koskenvuo, L. E., Svarvar, C., Suominen, S., Aittomäki, K., & Jahkola, T. (2013) · Scandinavian Journal of Surgery · doi:10.1177/1457496913490460 · Cited by 12
Cited by
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7112 · Cited by 2,954
Lheureux, S., Gourley, C., Vergote, I., & Oza, A. M. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32552-2 · Cited by 1,919
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Hereditary breast and ovarian cancer: new genes in confined pathways
Nielsen, F. C., van Overeem Hansen, T., & Sørensen, C. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.72 · Cited by 367
Tung, N. M., Boughey, J. C., Pierce, L. J., Robson, M. E., Bedrosian, I., Dietz, J. R., Dragun, A., Gelpi, J. B., Hofstatter, E. W., Isaacs, C. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00299 · Cited by 332
Metadata
- Authors
- Hartmann, L. C., & Lindor, N. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-02-04
- Volume
- 374
- Issue
- 5
- Pages
- 454-468
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2269179103
- Cited by
- 253
- References
- 96
- FWCI
- 30.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.